REVOLUTION MEDICINES INC's ticker is RVMD and the CUSIP is 76155X100. A total of 171 filers reported holding REVOLUTION MEDICINES INC in Q3 2023. The put-call ratio across all filers is 0.54 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $110,199,948 | -34.1% | 3,981,212 | -36.4% | 2.97% | -36.3% |
Q2 2023 | $167,336,979 | +55.9% | 6,255,588 | +26.2% | 4.66% | +18.9% |
Q1 2023 | $107,338,036 | +38.4% | 4,955,588 | +52.2% | 3.92% | +19.9% |
Q4 2022 | $77,548,106 | +20.8% | 3,255,588 | 0.0% | 3.27% | +23.4% |
Q3 2022 | $64,200,000 | +46.0% | 3,255,588 | +44.3% | 2.65% | +24.9% |
Q2 2022 | $43,961,000 | -4.8% | 2,255,588 | +24.6% | 2.12% | +14.9% |
Q1 2022 | $46,187,000 | +1.3% | 1,810,549 | 0.0% | 1.85% | +11.7% |
Q4 2021 | $45,572,000 | -33.3% | 1,810,549 | -27.1% | 1.65% | -38.0% |
Q3 2021 | $68,364,000 | -13.3% | 2,485,049 | 0.0% | 2.67% | -9.8% |
Q2 2021 | $78,875,000 | -41.6% | 2,485,049 | -15.6% | 2.96% | -41.6% |
Q1 2021 | $135,027,000 | +23.2% | 2,943,049 | +6.3% | 5.06% | +17.4% |
Q4 2020 | $109,587,000 | +49.9% | 2,768,049 | +31.7% | 4.31% | +8.3% |
Q3 2020 | $73,117,000 | +190.1% | 2,101,049 | +163.2% | 3.98% | +156.2% |
Q2 2020 | $25,202,000 | -17.7% | 798,286 | -42.9% | 1.55% | -45.6% |
Q1 2020 | $30,632,000 | – | 1,398,070 | – | 2.86% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Nextech Invest Ltd. | 4,839,529 | $133,958,163 | 40.59% |
Column Group LLC | 1,230,641 | $34,064,143 | 22.62% |
Boxer Capital, LLC | 4,684,264 | $129,660,428 | 6.90% |
Finepoint Capital LP | 427,000 | $11,819,360 | 5.89% |
Casdin Capital, LLC | 1,810,000 | $50,100,800 | 5.54% |
EcoR1 Capital, LLC | 5,577,863 | $154,395,248 | 5.21% |
DAFNA Capital Management LLC | 473,394 | $13,103,546 | 4.08% |
Artal Group S.A. | 2,529,737 | $70,023 | 3.00% |
BVF INC/IL | 3,981,212 | $110,199,948 | 2.97% |
Bellevue Group AG | 4,721,500 | $130,691,120 | 2.11% |